These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24940066)

  • 1. Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study.
    Jiang SP; Zhu ZY; Wu XL; Lu XY; Zhang XG; Wu BH
    Ther Clin Risk Manag; 2014; 10():405-12. PubMed ID: 24940066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.
    Jiang SP; Zhu ZY; Ma KF; Zheng X; Lu XY
    Scand J Infect Dis; 2013 Dec; 45(12):891-9. PubMed ID: 24024759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
    Saokaew S; Maphanta S; Thangsomboon P
    Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative.
    Griffin BR; Thomson A; Yoder M; Francis I; Ambruso S; Bregman A; Feller M; Johnson-Bortolotto S; King C; Bonnes D; Dufficy L; Wu C; Bansal A; Tad-Y D; Faubel S; Jalal D
    Am J Kidney Dis; 2019 Dec; 74(6):727-735. PubMed ID: 31540789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Lakshmipathy D; Ye X; Kuti JL; Nicolau DP; Asempa TE
    Crit Care Explor; 2024 Apr; 6(4):e1065. PubMed ID: 38533293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.
    Ruiz EF; Ortiz-Soriano VM; Talbott M; Klein BA; Thompson Bastin ML; Mayer KP; Price EB; Dorfman R; Adams BN; Fryman L; Neyra JA;
    Sci Rep; 2020 Nov; 10(1):20616. PubMed ID: 33244053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pharmaceutical care in an intensive care unit from China. A pre- and post-intervention study.
    Jiang SP; Zheng X; Li X; Lu XY
    Saudi Med J; 2012 Jul; 33(7):756-62. PubMed ID: 22821310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical pharmacist in an Indian Intensive Care Unit.
    Hisham M; Sivakumar MN; Veerasekar G
    Indian J Crit Care Med; 2016 Feb; 20(2):78-83. PubMed ID: 27076707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.
    Hall A; Crichton S; Dixon A; Skorniakov I; Kellum JA; Ostermann M
    Crit Care; 2020 Jun; 24(1):279. PubMed ID: 32487189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.
    Swartz RD; Bustami RT; Daley JM; Gillespie BW; Port FK
    Clin Nephrol; 2005 May; 63(5):335-45. PubMed ID: 15909592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of continuous renal replacement therapy during percutaneous drainage in severe acute pancreatitis patients: a retrospective cohort study].
    Sun B; Zhang C; Lin T; Liu S; Wang Z; Zhang J; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):714-718. PubMed ID: 31315729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].
    Li Y; Liu Y; Zhou C; Zhang Z; Zuo X; Li J; Cao Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):582-586. PubMed ID: 34112297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.